MEN1 and multiple endocrine neoplasia type 1: While biochemical tests have suggested a prevalence of the MEN1 syndrome at 0.01–0.175 per thousand [4, 5], the incidence of the syndrome based on genetic testing of the MEN1 gene in a large population is not yet clear.